NCT03766295 - Masitinib Plus Gemcitabine in Pancreatic Cancer | Biotech Hunter

Enrollment

377

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Locally Advanced or Metastatic Pancreatic Cancer

Interventions

DRUG

Masitinib

DRUG

Gemcitabine

DRUG

Placebo

Trial Locations (9)

Hospital AZ Sint-Jan, Bruges

General University Hospital of Patras, Pátrai

Polyclinique de Limoges site CHENIEUX, Limoges

Centre Hospitalier de Longjumeau, Longjumeau

Sanjeevani CBCC USA Cancer Hospital, Raipur

Omsk Clinical oncology dispensary Omsk, Omsk

National Oncology Institute, Bratislava

Institut Salah Azaiez de Cancerologie, Bab Saadoun

Center of Surgical Innovations, Kiev